• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Trump NIH appointee defends president’s research funding cuts, lays out new vision for future

by March 5, 2025
written by March 5, 2025

President Donald Trump’s pick to be the next Director of the National Institutes of Health (NIH), Dr. Jay Bhattacharya, spent much of his confirmation hearing Wednesday defending the president’s decision to put a 15% cap on indirect research costs dispersed by the NIH. 

Bhattacharya, a physician, Stanford professor of medicine and senior fellow at the university’s Institute for Economic Policy Research, would not explicitly say he disagreed with the cuts, or that, if confirmed, he would step in to stop them. Rather, he said he would ‘follow the law,’ while also investigating the impact of the cuts and ensuring every NIH researcher doing work that advances the health outcomes of Americans has the resources necessary to do their work.

Bhattacharya also laid out a new, decentralized vision for future research at NIH that he said will be aimed at embracing dissenting ideas and transparency, while focusing on research topics that have the best chance at directly benefiting health outcomes of Americans. Bhattacharya added that he wants to rid the agency’s research portfolio of other ‘frivolous’ efforts, that he says do little to directly benefit health outcomes.

‘There’s a lot of distrust about where the money goes because the trust in the public health establishment has collapsed since the pandemic,’ Bhattacharya said. ‘I think transparency regarding indirect costs is absolutely worthwhile. It’s something that universities can fix by working together to make sure that where that money goes is made clear.’  

Democratic Sens. Angela Alsobrooks of Maryland and Ed Markey of Massachusetts both pressed Bhattacharya specifically about research that looks into health issues that impact minorities — an area Democrats worry could be undermined at the NIH due to Trump’s campaign against the Left’s views on diversity, equity, and inclusion (DEI). 

‘The health needs of minority populations in this country are a vital priority for me … I want to make sure the research that the NIH does addresses those health needs, and I don’t see anything in the president’s orders that contradicts that, in fact, quite to the contrary,’ Bhattacharya said. ‘What I’ve heard from [Secretary Robert F. Kennedy Jr.] and from the president is ‘Let’s make America Healthy,’ meaning all Americans.’

When Alsobrooks cited a project Bhattacharya worked on related to Alzheimer’s disease, which included mentoring ‘diverse’ professionals, he said that his understanding of that part of the project meant mentoring researchers with a diverse set of ideas, not a diverse set of skin colors. 

‘I think fundamentally what matters is: Do scientists have an idea that advances the scientific field they’re in?’ Bhattacharya replied. ‘Do they have an idea that ends up addressing the health needs of Americans?’

Bhattacharya acknowledged that ‘identifying’ health disparities among minority groups is important, but emphasized the need for research that drives meaningful outcomes.

Bhattacharya also challenged the premise of a similar line of questioning from Markey, who argued Trump was utilizing ideological flashpoints to ‘slow’ life-saving research.

‘I don’t agree with you, senator, that President Trump is opposed to [speeding up research]. In fact, quite the opposite, he is quite in favor of making America healthy,’ Bhattacharya told Markey. ‘I don’t believe that ideology ought to determine whether one gets research or not.’

In addition to addressing numerous questions from Democrats about Trump’s funding cuts, Bhattacharya also outlined his plans to reform the NIH’s research portfolio during his Wednesday confirmation hearing.

Trump’s NIH nominee said he hopes to focus on cutting-edge research and other ‘big ideas’ as opposed to continuing to put all the federal government’s money into research that doesn’t involve the same ambitious goals. He also briefly spoke about improving the frequency of ‘validation research’ and increasing the number of NIH applications funded for younger investigators.

Concerns from Republicans during the hearing included whether Bhattacharya would continue supporting research investigating the link between vaccines and autism, something Sen. Bill Cassidy, R-La., said has been proven over and over again to have no link, and whether he will permit the continued use of aborted fetal tissue in NIH-funded research.

Bhattacharya agreed with Cassidy that the linkage between autism and vaccines is clear — there isn’t one. However, he acknowledged that others may disagree with him. In line with his commitment to embracing dissenting ideas and promoting free speech in medical research, he suggested that commissioning studies could help the public gain a clearer understanding that no link exists.

On the issue of halting the use of aborted fetal tissue, during Trump’s first term, he banned its use, and Bhattacharya said he would follow the president’s lead on the issue.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
SEE IT: Republicans reveal expectations for Elon Musk’s closed-door meeting with lawmakers tonight
next post
Resolution punishing Al Green clears Dem blockade, advances to House-wide vote after Trump speech

related articles

Hawley blasts FDA approval of new abortion drug,...

October 2, 2025

Trump’s DOGE savings dwarfed by Medicare, Social Security...

October 2, 2025

FLASHBACK: James Comey urged officials to always prosecute...

October 2, 2025

The agency staff Vought might recommend cutting and...

October 2, 2025

Reagan-appointed judge, once rebuked by Supreme Court, continues...

October 2, 2025

‘Real consequences’: Food aid, flood insurance, FEMA funds...

October 2, 2025

Trump must triple severely outdated nuke arsenal to...

October 2, 2025

White House says federal layoffs could hit ‘thousands’...

October 2, 2025

Johnson shuts door on negotiating shutdown deal as...

October 2, 2025

Democrats refuse to budge over Obamacare fight as...

October 2, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Time is running out to stop Iran from making nuclear bomb: ‘Dangerous territory’

    April 8, 2025
  • Legal group sues FDA over puberty blocker records, citing alleged Biden-era cover-up

    August 30, 2025
  • Trump: ‘We’ll never stop looking’ for American journalist kidnapped in Syria, Austin Tice

    April 1, 2025
  • Morning Glory: Top 10 lessons from the landslide

    November 12, 2024
  • Dems who lashed out at Trump for being ‘threat to democracy’ flip script with last-minute delay tactics

    February 7, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,247)
  • Investing (634)
  • Stock (935)

Latest Posts

  • Ramaswamy endorses Winsome Earle-Sears for Virginia governor, rally planned next week in swing suburb

    September 10, 2025
  • Solana and Cardano: Cardano has recovered to the EMA 200

    August 29, 2024
  • Houston Rockets owner among trio of Trump ambassador nominees confirmed by Senate

    April 30, 2025

Recent Posts

  • Bernie Sanders, AOC and other anti-Trump progressives haul in big bucks for 2026 midterms

    April 16, 2025
  • McClain elected to replace Stefanik in House GOP leadership

    November 14, 2024
  • WATCH: Rubio on Dems saying they regret voting for him: ‘Confirmation I’m doing a good job’

    May 22, 2025

Editor’s Pick

  • Inside the $1 billion berry startup backed by Ray Dalio’s family office

    April 23, 2025
  • Trump stands by RFK Jr. after heated Senate hearing: ‘I like the fact that he’s different’

    September 5, 2025
  • SoundHound stock surges 18% following acquisition of Amelia AI: Good time to buy?

    August 8, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock